Compare DOYU & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOYU | ECOR |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4M | 100.3M |
| IPO Year | 2019 | 2018 |
| Metric | DOYU | ECOR |
|---|---|---|
| Price | $3.89 | $7.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $4.80 | ★ $18.24 |
| AVG Volume (30 Days) | 25.5K | ★ 109.5K |
| Earning Date | 11-23-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $25.01 |
| Revenue Next Year | N/A | $32.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $3.42 | $4.41 |
| 52 Week High | $7.23 | $12.70 |
| Indicator | DOYU | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 45.87 |
| Support Level | $3.42 | $6.94 |
| Resistance Level | $4.87 | $8.21 |
| Average True Range (ATR) | 0.17 | 0.84 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 87.72 | 38.78 |
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company aims to build an integrated game-centric ecosystem of livestreaming, video, voice, graphic content, and other interactive and community features. The company operates the platform both on mobile apps and PC portals, through which users can enjoy immersive and interactive games and entertainment livestreaming, access a wide array of video and graphic content, and participate in community events and discussions.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.